Ulcerative colitis and its correlation with the incidence of colorectal cancer

Authors

  • Felix Ongko Tarumanagara University, Indonesia
  • Erwin Kurniawan Santosa Tarumanagara University, Indonesia
  • Edward Then Tarumanagara University, Indonesia
  • Lucky Anthonny Setiawan Tarumanagara University, Indonesia
  • Vivian Ongriana Atma Jaya University, Indoonesia

DOI:

https://doi.org/10.35335/midwifery.v11i1.1207

Keywords:

Cancer, Colorectal cancer, Ulcerative colitis

Abstract

The purpose of this research to further reviewed the pathogenesis, risk factors, screening, and preventive interventions for colorectal cancer associated with ulcerative colitis.  The research method used descriptive qualitative through the Literature Review (LR) approach. The data source used a secondary source. Data analysis technique selects literature based on title, year, and indexed articles, then reviews articles that match the subject matter. A literature search was performed using databases, such as PubMed, Cochrane Library, and Science Direct. Colitis-associated neoplasia is thought to result from chronic inflammation, which induces changes in epithelial proliferation, survival, and migration through the effects of various chemokines and cytokines. The risk factors are in three main categories: disease-related, patient-related, and pathology-related. The most reliable screening test is colonoscopy, parallel with a structured endoscopic surveillance program that includes ongoing medical management for disease control. There are several chemopreventive options for the early prevention of colorectal cancer in cases of ulcerative colitis.   In general, long-standing chronic inflammation in the intestinal mucosa increases the risk of colorectal cancer due to genetic and molecular alterations. Identifying high-risk groups and colonoscopic surveillance programs have been considered useful early detection measures.

Downloads

Download data is not yet available.

References

Axelrad, J. E., Faye, A., Slaughter, J. C., Harpaz, N., Itzkowitz, S. H., & Shah, S. C. (2022). Colorectal Strictures in Patients With Inflammatory Bowel Disease Do Not Independently Predict Colorectal Neoplasia. Inflammatory Bowel Diseases, 28(6), 855–861. https://doi.org/10.1093/ibd/izab177

Azuara, D., Rodriguez-Moranta, F., De Oca, J., Sanjuan, X., Guardiola, J., Lobaton, T., Wang, A., Boadas, J., Piqueras, M., Monfort, D., Galter, S., Esteller, M., Moreno, V., & Capellá, G. (2013). Novel methylation panel for the early detection of neoplasia in high-risk ulcerative colitis and Crohn’s colitis patients. Inflammatory Bowel Diseases, 19(1), 165–173. https://doi.org/10.1002/ibd.22994

Bopanna, S., Ananthakrishnan, A. N., Kedia, S., Yajnik, V., & Ahuja, V. (2017). Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis. The Lancet Gastroenterology and Hepatology, 2(4), 269–276. https://doi.org/10.1016/S2468-1253(17)30004-3

Bye, W. A., Ma, C., Nguyen, T. M., Parker, C. E., Jairath, V., & East, J. E. (2018). Strategies for detecting colorectal cancer in patients with inflammatory bowel disease: A cochrane systematic review and meta-analysis. American Journal of Gastroenterology, 113(12), 1801–1809. https://doi.org/10.1038/s41395-018-0354-7

Choi, C. H. R., Al Bakir, I., Ding, N. S. J., Lee, G. H., Askari, A., Warusavitarne, J., Moorghen, M., Humphries, A., Ignjatovic-Wilson, A., Thomas-Gibson, S., Saunders, B. P., Rutter, M. D., Graham, T. A., & Hart, A. L. (2019). Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: A large single-centre study. Gut, 68(3), 414–422. https://doi.org/10.1136/gutjnl-2017-314190

Choi, C. H. R., Bakir, I. Al, Hart, A. L., & Graham, T. A. (2017). Clonal evolution of colorectal cancer in IBD. Nature Reviews Gastroenterology and Hepatology, 14(4), 218–229. https://doi.org/10.1038/nrgastro.2017.1

Choi, C. H. R., Rutter, M. D., Askari, A., Lee, G. H., Warusavitarne, J., Moorghen, M., Thomas-Gibson, S., Saunders, B. P., Graham, T. A., & Hart, A. L. (2015). Forty-year analysis of colonoscopic surveillance program for neoplasia in ulcerative colitis: An updated overview. American Journal of Gastroenterology, 110(7), 1022–1034. https://doi.org/10.1038/ajg.2015.65

Choi, J. kyu, Kim, D. W., Shin, S. Y., Park, E. C., & Kang, J. G. (2016). Effect of ulcerative colitis on incidence of colorectal cancer: Results from the nationwide population-based cohort study (2003-2013). Journal of Cancer, 7(6), 681–686. https://doi.org/10.7150/jca.14264

de Campos Silva, E. F., Baima, J. P., de Barros, J. R., Tanni, S. E., Schreck, T., Saad-Hossne, R., & Sassaki, L. Y. (2020). Risk factors for ulcerative colitis-associated colorectal cancer: A retrospective cohort study. Medicine, 99(32), e21686. https://doi.org/10.1097/MD.0000000000021686

Dulai, P. S., Sandborn, W. J., & Gupta, S. (2016). Colorectal cancer and dysplasia in inflammatory bowel disease: A review of disease Epidemiology, Pathophysiology, and Management. Cancer Prevention Research, 9(12), 887–894. https://doi.org/10.1158/1940-6207.CAPR-16-0124

Fisher, D. A., Princic, N., Miller-Wilson, L. A., Wilson, K., Fendrick, A. M., & Limburg, P. (2021). Utilization of a Colorectal Cancer Screening Test among Individuals with Average Risk. JAMA Network Open, 4(9). https://doi.org/10.1001/jamanetworkopen.2021.22269

Frick, A., Khare, V., Paul, G., Lang, M., Ferk, F., Knasmüller, S., Beer, A., Oberhuber, G., & Gasche, C. (2018). Overt increase of oxidative stress and DNA damage in murine and human colitis and colitis-associated neoplasia. Molecular Cancer Research, 16(4), 634–642. https://doi.org/10.1158/1541-7786.MCR-17-0451

Fumery, M., Dulai, P. S., Gupta, S., Prokop, L. J., Ramamoorthy, S., Sandborn, W. J., & Singh, S. (2017). Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients With Ulcerative Colitis With Low-Grade Dysplasia: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology, 15(5), 665-674.e5. https://doi.org/10.1016/j.cgh.2016.11.025

Gong, J., Zhu, L., Guo, Z., Li, Y., Zhu, W., Li, N., & Li, J. (2013). Use of thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel diseases: A meta-analysis. PLoS ONE, 8(11). https://doi.org/10.1371/journal.pone.0081487

Gordillo, J., Cabré, E., Garcia-Planella, E., Ricart, E., Ber-Nieto, Y., Márquez, L., Rodríguez-Moranta, F., Ponferrada, ÃÂÂ., Vera, I., Gisbert, J. P., Barrio, J., Esteve, M., Merino, O., Muñoz, F., & Domènech, E. (2015). Thiopurine Therapy Reduces the Incidence of Colorectal Neoplasia in Patients with Ulcerative Colitis. Data from the ENEIDA Registry. Journal of Crohn’s & colitis, 9(12), 1063–1070. https://doi.org/10.1093/ecco-jcc/jjv145

Hata, K., Anzai, H., Ikeuchi, H., Futami, K., Fukushima, K., Sugita, A., Uchino, M., Higashi, D., Itabashi, M., Watanabe, K., Koganei, K., Araki, T., Kimura, H., Mizushima, T., Ueda, T., Ishihara, S., & Suzuki, Y. (2019). Surveillance Colonoscopy for Ulcerative Colitis-Associated Colorectal Cancer Offers Better Overall Survival in Real-World Surgically Resected Cases. American Journal of Gastroenterology, 114(3), 483–489. https://doi.org/10.14309/ajg.0000000000000117

Jess, T., Lopez, A., Andersson, M., Beaugerie, L., & Peyrin-Biroulet, L. (2014). Thiopurines and Risk of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease: A Meta-analysis. Clinical Gastroenterology and Hepatology, 12(11), 1793-1800.e1. https://doi.org/10.1016/j.cgh.2014.05.019

Jess, T., Simonsen, J., Jorgensen, K. T., Pedersen, B. V., Nielsen, N. M., & Frisch, M. (2012). Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology, 143(2), 375-381.e1. https://doi.org/10.1053/j.gastro.2012.04.016

Jong, M. E., Gillis, V. E. L. M., Derikx, L. A. A. P., & Hoentjen, F. (2020). No increased risk of colorectal neoplasia in patients with inflammatory bowel disease and postinflammatory polyps. Inflammatory Bowel Diseases, 26(9), 1383–1389. https://doi.org/10.1093/ibd/izz261

Kisiel, J. B., & Ahlquist, D. A. (2013). Stool DNA testing for cancer surveillance in inflammatory bowel disease: An early view. Therapeutic Advances in Gastroenterology, 6(5), 371–380. https://doi.org/10.1177/1756283X13487941

Kucharzik, T., Ellul, P., Greuter, T., Rahier, J. F., Verstockt, B., Abreu, C., Albuquerque, A., Allocca, M., Esteve, M., Farraye, F. A., Gordon, H., Karmiris, K., Kopylov, U., Kirchgesner, J., Macmahon, E., Magro, F., Maaser, C., De Ridder, L., Taxonera, C., … Vavricka, S. (2021). ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease. Journal of Crohn’s and Colitis, 15(6), 879–913. https://doi.org/10.1093/ecco-jcc/jjab052

Li, W., Zhao, T., Wu, D., Li, J., Wang, M., Sun, Y., & Hou, S. (2022). Colorectal Cancer in Ulcerative Colitis: Mechanisms, Surveillance and Chemoprevention. Current Oncology, 29(9), 6091–6114. https://doi.org/10.3390/curroncol29090479

Lopez, A., Pouillon, L., Beaugerie, L., Danese, S., & Peyrin-Biroulet, L. (2018). Colorectal cancer prevention in patients with ulcerative colitis. Best Practice and Research: Clinical Gastroenterology, 32–33, 103–109. https://doi.org/10.1016/j.bpg.2018.05.010

Lu, M. J., Qiu, X. Y., Mao, X. Q., Li, X. T., & Zhang, H. J. (2018). Systematic review with meta-analysis: thiopurines decrease the risk of colorectal neoplasia in patients with inflammatory bowel disease. Alimentary Pharmacology and Therapeutics, 47(3), 318–331. https://doi.org/10.1111/apt.14436

Luo, C., & Zhang, H. (2017). The Role of Proinflammatory Pathways in the Pathogenesis of Colitis-Associated Colorectal Cancer. Mediators of Inflammation, 2017. https://doi.org/10.1155/2017/5126048

Lutgens, M. W. M. D., van Oijen, M. G. H., van der Heijden, G. J. M. G., Vleggaar, F. P., Siersema, P. D., & Oldenburg, B. (2013). Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Inflammatory bowel diseases, 19(4), 789–799. https://doi.org/10.1097/MIB.0b013e31828029c0

Magro, F., Gionchetti, P., Eliakim, R., Ardizzone, S., Armuzzi, A., Barreiro-de Acosta, M., Burisch, J., Gecse, K. B., Hart, A. L., Hindryckx, P., Langner, C., Limdi, J. K., Pellino, G., Zagórowicz, E., Raine, T., Harbord, M., & Rieder, F. (2017). Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: Definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. Journal of Crohn’s and Colitis, 11(6), 649–670. https://doi.org/10.1093/ecco-jcc/jjx008

Pasternak, B., Svanström, H., Schmiegelow, K., Jess, T., & Hviid, A. (2013). Use of azathioprine and the risk of cancer in inflammatory bowel disease. American Journal of Epidemiology, 177(11), 1296–1305. https://doi.org/10.1093/aje/kws375

Pereira, C., Grácio, D., Teixeira, J. P., & Magro, F. (2015). Oxidative Stress and DNA Damage: Implications in Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 21(10), 2403–2417. https://doi.org/10.1097/MIB.0000000000000506

Rennoll, S. (2015). Regulation of MYC gene expression by aberrant Wnt/β-catenin signaling in colorectal cancer . World Journal of Biological Chemistry, 6(4), 290. https://doi.org/10.4331/wjbc.v6.i4.290

Reznicek, E., Arfeen, M., Shen, B., & Ghouri, Y. (2021). Colorectal Dysplasia and Cancer Surveillance in Ulcerative Colitis. Diseases, 9(4), 86. https://doi.org/10.3390/diseases9040086

Robles, A. I., Traverso, G., Zhang, M., Roberts, N. J., Khan, M. A., Joseph, C., Lauwers, G. Y., Selaru, F. M., Popoli, M., Pittman, M. E., Ke, X., Hruban, R. H., Meltzer, S. J., Kinzler, K. W., Vogelstein, B., Harris, C. C., & Papadopoulos, N. (2016). Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers. Gastroenterology, 150(4), 931–943. https://doi.org/10.1053/j.gastro.2015.12.036

Rubin, D. T., Ananthakrishnan, A. N., Siegel, C. A., Sauer, B. G., & Long, M. D. (2019). ACG Clinical Guideline: Ulcerative Colitis in Adults. American Journal of Gastroenterology, 114(3), 384–413. https://doi.org/10.14309/ajg.0000000000000152

Samadder, N. J., Valentine, J. F., Guthery, S., Singh, H., Bernstein, C. N., Leighton, J. A., Wan, Y., Wong, J., Boucher, K., Pappas, L., Rowe, K., Burt, R. W., Curtin, K., & Smith, K. R. (2019). Family History Associates With Increased Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases. Clinical Gastroenterology and Hepatology, 17(9), 1807-1813.e1. https://doi.org/10.1016/j.cgh.2018.09.038

Saraggi, D., Fassan, M., Mescoli, C., Scarpa, M., Valeri, N., Michielan, A., D’Incá, R., & Rugge, M. (2017). The molecular landscape of colitis-associated carcinogenesis. Digestive and Liver Disease, 49(4), 326–330. https://doi.org/10.1016/j.dld.2016.12.011

Scarpa, M., Castagliuolo, I., Castoro, C., Pozza, A., Scarpa, M., Kotsafti, A., & Angriman, I. (2014). Inflammatory colonic carcinogenesis: A review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis. World Journal of Gastroenterology, 20(22), 6774–6785. https://doi.org/10.3748/wjg.v20.i22.6774

Selinger, C. P., Andrews, J. M., Titman, A., Norton, I., Jones, D. B., McDonald, C., Barr, G., Selby, W., Leong, R., Andrews, J., Barnes, P., Barr, G., Bye, W., Chapman, G., Cowlishaw, J., Gallagher, N., Gillies, M., Goulston, K., Goulston, S., … Selby, W. (2014). Long-term Follow-up Reveals Low Incidence of Colorectal Cancer, but Frequent Need for Resection, Among Australian Patients With Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology, 12(4), 644–650. https://doi.org/10.1016/j.cgh.2013.05.017

Shah, S. C., & Itzkowitz, S. H. (2022). Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management. Gastroenterology, 162(3), 715-730.e3. https://doi.org/10.1053/j.gastro.2021.10.035

Siegel, R., Naishadham, D., & Jemal, A. (2012). CA: A Cancer Journal for Clinicians. CA: A Cancer Journal for Clinicians, 62(1), 10–29. https://doi.org/10.3322/caac.20138

Söderlund, S., Granath, F., Broström, O., Karlén, P., Löfberg, R., Ekbom, A., & Askling, J. (2010). Inflammatory Bowel Disease Confers a Lower Risk of Colorectal Cancer to Females Than to Males. Gastroenterology, 138(5). https://doi.org/10.1053/j.gastro.2010.02.007

Takehiro, H., Daisuke, H., Kohei, W., Tsukasa, Y., Yoshihiro, Y., & Hiroshi, N. (2020). Immunological mechanisms in Inflammation-Associated Colon carcinogenesis. International Journal of Molecular Sciences, 21, 3062.

Waldner, M. J., & Neurath, M. F. (2015). Mechanisms of Immune Signaling in Colitis-Associated Cancer. Cmgh, 1(1), 6–16. https://doi.org/10.1016/j.jcmgh.2014.11.006

Wijnands, A. M., de Jong, M. E., Lutgens, M. W. M. D., Hoentjen, F., Elias, S. G., & Oldenburg, B. (2021). Prognostic Factors for Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: Systematic Review and Meta-analysis. Gastroenterology, 160(5), 1584–1598. https://doi.org/10.1053/j.gastro.2020.12.036

Yvellez, O. V., Rai, V., Sossenheimer, P. H., Hart, J., Turner, J. R., Weber, C., El Jurdi, K., & Rubin, D. T. (2021). Cumulative Histologic Inflammation Predicts Colorectal Neoplasia in Ulcerative Colitis: A Validation Study. Inflammatory Bowel Diseases, 27(2), 203–206. https://doi.org/10.1093/ibd/izaa047

Downloads

Published

2023-04-27

How to Cite

Ongko, F. (2023) “Ulcerative colitis and its correlation with the incidence of colorectal cancer”, Science Midwifery, 11(1), pp. 165–173. doi: 10.35335/midwifery.v11i1.1207.

Issue

Vol. 11 No. 1 (2023): April: Midwifery and Health Sciences

Section

Articles